Abstract |
Heat shock proteins (HSPs) are involved in the activation of both adaptive and innate immune systems. Here, we report that vaccination with autologous tumor-derived HSP96 of colorectal cancer patients, radically resected for liver metastases, induced a significant boost of natural killer (NK) activity detected as cytokine secretion and cytotoxicity in the presence of NK-sensitive targets. Increased NK activity was associated with a raise in CD3-CD56+ NK and/or CD3+CD56+ NK-like T cells, displaying enhanced expression of NKG2D and/or NKp46 receptors. Up-regulated expression of CD83 and CD40 and increased interleukin-12 release on stimulation were observed in CD14+ cells from post-HSP96 peripheral blood mononuclear cells, suggesting an indirect pathway of NK stimulation by HSP96-activated monocytes. Additionally, CD3-CD56+ and CD3+CD56+ lymphocytes were found to undergo functional and phenotypic activation on in vitro exposure to HSP96 even in the absence of monocytes, supporting a potential direct activity of HSP96 on these cell subsets. This evidence was confirmed by the specific binding of FITC-conjugated HSP96 to a subset of both CD3-CD56+ and CD3+CD56+ cells in peripheral blood mononuclear cells from colorectal cancer patients. Altogether, these findings identify the activation of the NK compartment as an additional immunologic effect of autologous tumor-derived HSP96 administration in cancer patients.
|
Authors | Lorenzo Pilla, Paola Squarcina, Jorgelina Coppa, Vincenzo Mazzaferro, Veronica Huber, Daniela Pende, Cristina Maccalli, Gloria Sovena, Luigi Mariani, Chiara Castelli, Giorgio Parmiani, Licia Rivoltini |
Journal | Cancer research
(Cancer Res)
Vol. 65
Issue 9
Pg. 3942-9
(May 01 2005)
ISSN: 0008-5472 [Print] United States |
PMID | 15867395
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cancer Vaccines
- Heat-Shock Proteins
- vitespin
|
Topics |
- Cancer Vaccines
(immunology, therapeutic use)
- Colorectal Neoplasms
(blood, immunology, therapy)
- Disease-Free Survival
- Heat-Shock Proteins
(immunology, therapeutic use)
- Humans
- Immunotherapy, Active
(methods)
- Killer Cells, Natural
(immunology)
- Leukocytes, Mononuclear
(immunology)
- Lymphocyte Activation
- T-Lymphocytes
(immunology)
|